Associated Medical Professionals Syracuse NY: A 2026 Patient’s Vetting Guide

Introduction: Why Searching “Associated Medical Professionals Syracuse NY” Should Lead to More Than an Address

Most people who search for “Associated Medical Professionals Syracuse NY” want practical details. They are looking for an address, a phone number, office hours, or a physician roster before a urology or cancer-care appointment. Online directories and listing sites answer these “where and who” questions, and so does the practice’s own website.

These sources do not answer a harder question: should a patient feel confident booking there?

TopDoctor Magazine is not a directory and does not speak for Associated Medical Professionals (AMP). Its purpose here is to translate peer-reviewed research on private-equity-owned medicine into plain-language questions that patients can bring to an appointment. The framework in this guide uses AMP as its example, but it applies to any large, multi-provider specialty group in the country.

The guide covers three things: how AMP is structured, why ownership matters, and seven questions to ask before booking.

Who Is Associated Medical Professionals of NY? A Quick Orientation

Associated Medical Professionals of NY is a multi-specialty urology and cancer-care group. It is headquartered at 1226 East Water Street, Syracuse, NY 13210, and serves Cayuga, Cortland, Madison, Oneida, Onondaga, and Oswego Counties. The practice describes its focus as treating urological conditions and cancers, with care delivered by urologists, radiation oncologists, and pathologists.

This section is a factual orientation. It is not an endorsement or a directory listing.

Practice History: Built Through Successive Mergers

AMP began as a merger of Syracuse Urology Associates, P.C., Associated Urologists of CNY, and Syracuse Radiation Oncology. In 2009 it merged with CNY Urology, P.C. In 2011 it absorbed Urology Consultants of Syracuse, Urology Specialists of CNY, Mohawk Valley Urology, and Utica Urology Associates.

Practices that grow through repeated mergers tend to become attractive targets for private equity roll-ups, which is what happened to AMP.

Scope of Services Today

As of early 2026, AMP operates across 18 locations in Central New York, including eight offices and 13 hospitals. Physician directory listings show 37 physicians across 10 specialty areas, covering urology, radiation oncology, pathology, and interventional and diagnostic radiology.

The group’s in-house capabilities include:

• A nationally recognized Research Division running prostate cancer clinical trials
• PET/CT imaging
• A laboratory
• An in-office dispensary
• An outpatient interventional radiology suite

In March 2024, according to CEO Dr. Christopher Pieczonka, AMP launched an outpatient Interventional Radiology Center with Prostate Centers USA to expand minimally invasive treatment for BPH (enlarged prostate).

The 2020 Acquisition by U.S. Urology Partners

On November 23, 2020, AMP was acquired by U.S. Urology Partners, a platform backed by the private equity firm General Atlantic that partners with independent community urology practices.

A “PE-backed platform” works like this in practice: an investment firm funds a central company, which acquires multiple practices, centralizes management functions such as billing and staffing, and grows mainly through further acquisitions. Physicians still deliver care, but business decisions increasingly run through the parent organization.

For a prospective patient, this ownership fact matters more than the address or phone number.

Why Ownership Structure Matters Before Booking

Ownership is not a concern unique to AMP. It applies to any consolidated specialty group, and patients will encounter more of these each year.

What Private Equity Ownership Changes in a Medical Practice

The PE roll-up model buys several practices, standardizes their operations, and pursues efficiency and growth targets. According to the American Urological Association’s advocacy publication, private equity investment in health care grew from $41 billion in 2010 to nearly $200 billion in 2019.

The model has potential benefits. Capital can fund new equipment and research infrastructure, such as AMP’s clinical trials program. Analysts at Wolters Kluwer note the trade-off: gains in efficiency can come alongside a risk of prioritizing costs and revenue over patient welfare.

What the Peer-Reviewed Research Actually Shows

Several studies inform the questions in this guide:

• MIPS performance: A study in Urology Practice found that PE acquisition of urology practices was associated with significantly lower scores in Medicare’s Merit-based Incentive Payment System, a federal measure of quality and cost.
• Prostate cancer management: Research published in PMC on the immediate effects of PE acquisition on newly diagnosed prostate cancer concluded that more study is needed on care patterns and costs.
• Physician satisfaction: A JAMA Internal Medicine survey cited by the AUA found that only 44.8% of PE-employed physicians reported high professional satisfaction, compared with 74.4% of physicians outside PE ownership. Low satisfaction can lead to turnover, which affects continuity of care.

These findings describe patterns across many practices. They are not verdicts on any single provider. They do justify specific follow-up questions.

The Regulatory Blind Spot Patients Should Know About

Most physician-group acquisitions, including deals like AMP’s, fall below the Hart-Scott-Rodino disclosure threshold (about $114.4 million in 2023). As a result, the FTC generally does not review them. The effects of consolidation on markets and quality may not become visible to patients or regulators for years.

Patients therefore should not assume that a regulator has already vetted a practice after its sale. They need to do some of that checking themselves.

The Vetting Gap: What Directories and Practice Websites Don’t Tell Patients

Current online content about AMP leaves an evaluation gap that this guide aims to fill.

The Limits of Directory Listings

Yelp, Vitadox, WebMD, and BBB profiles mostly republish address, phone, hours, and a basic specialty list, without helping patients weigh one option against another. The BBB lists AMP as “Not BBB Accredited,” a surface-level data point with no explanation attached. None of these platforms mention the U.S. Urology Partners ownership or explain what it means for care.

The Limits of the Practice’s Own Marketing

AMP’s website (ampofny.com) and its press releases focus on promotion: new physician hires, service launches, and merger history. Marketing materials are not designed to help patients evaluate PE ownership, provider consistency, or referral patterns.

Third-party patient reviews on directory sites are mixed. Some reviewers praise the practice’s long history and specialist depth. Others mention long wait times, being seen by physician assistants rather than physicians, and pressure toward tests or treatments that were not fully explained.

Employee Reviews as an Indirect Signal

On Indeed, AMP holds a low overall rating of roughly 2.3 out of 5, with reviewers citing management and culture issues. Glassdoor shows similar signals. Internal culture complaints do not measure clinical quality. They can, however, indicate whether staffing is stable, and staffing stability affects continuity of care. Patients should treat this as one data point alongside clinical criteria, not as a replacement for them.

A Physician-Informed Framework: Questions to Ask Before Booking with Any Multi-Provider Specialty Group

The following checklist is the core of this guide. It combines guidance from the AUA and the American Board of Urology with research specific to private equity ownership.

1. Who Owns This Practice, and Since When?

Patients can search for a practice’s acquisition history. For AMP, the answer is U.S. Urology Partners, backed by General Atlantic, since November 2020. Learning which other practices the parent company owns can reveal patterns in how it tends to manage its portfolio.

2. Will Patients See a Physician or a PA/NP, and How Is That Decided?

Some patients report being seen by PAs without being told beforehand. When scheduling, patients can ask: “Which provider type will conduct this visit, and under what circumstances does a physician become involved?” In a group with 37 physicians across 10 specialty areas, the way visits are assigned is not always clear to patients.

3. How Is This Specific Provider Board-Certified and Credentialed?

Patients should verify board certification through the American Board of Urology or the ABMS database rather than relying on a website bio. Board certification is widely considered one of the most important factors in choosing a urologist. Because AMP offers several specialties, patients should also ask about certification in the relevant field, such as radiation oncology or interventional radiology.

4. If Referred for Imaging, Labs, or Radiation, Where Does the Referral Go?

A vertically integrated group provides multiple stages of care under one roof. AMP’s in-house PET/CT, laboratory, dispensary, and radiation oncology services mean referrals can stay within the group, and the group earns revenue from them. Patients can ask whether in-house referral is standard and whether outside options exist. The goal is to gather facts, not to accuse anyone. Keeping care in one place can be a real convenience when the practice explains it openly.

5. What Is This Provider’s Specific Experience with a Patient’s Condition or Procedure?

Patients should ask about how often the provider performs the relevant procedure and what their outcomes are, whether for BPH treatment or prostate cancer management. AMP highlights its prostate cancer trials and its IR Center for BPH. Patients should ask about the individual provider’s experience with these services, not only the practice’s.

6. How Does This Practice Communicate Treatment Options and Risks?

The AUA describes a good urologist as one who explains conditions, options, and risks clearly and with empathy. During a first visit or phone consultation, patients can notice whether answers are clear or rushed and scripted. This question also addresses review complaints about pressure toward tests that were not fully discussed.

7. What Do Public Records Show About Malpractice or Disciplinary History?

Patients should check state licensing board records and malpractice history for the specific named provider. Large groups usually market their reputation at the practice level, so checking each individual provider becomes more important, not less.

Applying the Framework to Associated Medical Professionals of NY

What’s Publicly Verifiable About AMP Right Now

The following facts about AMP can be confirmed publicly:

• Ownership by U.S. Urology Partners, backed by General Atlantic, since 2020
• 18 locations
• 37 physicians across 10 specialties
• An in-house research division and IR center

These facts establish the group’s size and structure. They do not answer questions about quality of care.

Questions Worth Asking AMP Directly

Adapted to AMP, the framework produces questions such as:

• “Which provider will I see for my consult, and are they a physician or a PA?”
• “If I need imaging, will it be done at AMP’s PET/CT facility, and can I go elsewhere if I choose?”
• “How many of these procedures has my assigned provider performed?”

Before the visit, patients should check physician names against the American Board of Urology database and the practice’s own physician listings.

Red Flags vs. Reasonable Trade-offs in Consolidated Specialty Practices

Signs of a Well-Run Multi-Provider Group

• Clear disclosure of which provider a patient will see and why
• Willingness to explain referral pathways and how in-house services fit together
• Investment in research and updated technology, such as AMP’s prostate cancer trials and IR Center
• Clear, unhurried communication about treatment options

Signs That Warrant Extra Caution

• Vague or evasive answers about credentials or ownership
• A pattern of being seen by non-physician providers without being told in advance
• Pressure toward in-house tests or procedures without a clear clinical reason
• Persistent staff turnover or low morale, which may signal problems with continuity of care

Conclusion: Vetting a Practice Is a Skill, Not a One-Time Search

AMP is one example of a growing category: large, PE-backed specialty groups that are now common in urology and other fields. An address and phone number confirm that a patient has found the practice. The seven-question framework helps the patient decide whether the practice is the right fit.

Questions about ownership, which provider will deliver care, and where referrals go are well-founded. Research published in Urology Practice, PMC, and AUA publications supports them. Patients can apply the same framework to any multi-provider specialty group.

Next Step: Taking the Framework Into the Next Appointment

Readers can save or print the seven-question checklist before their next specialist visit. TopDoctor Magazine publishes further content on choosing providers and understanding how healthcare businesses operate, in line with its mission to help readers make informed healthcare decisions. Readers who want future patient-education guides, including more articles on evaluating specialty practices, can subscribe to the free TopDoctor Magazine newsletter.